After experiencing a record-setting two years in Care-at-Home M&A, 2022 remains sluggish. A few key facts illuminate this decline. One, fewer companies are going to market in 2022, compared with 2020 to 2021. “Transaction volume from late 2020 through 2021, relative to historical periods, was up almost 40%. This was driven by sellers trying to get their transactions closed before the then-pending capital gains tax rate increase. This never came to fruition, but the threat has loomed since the current administration took office, only subsiding in early 2022.” Mertz Taggart Managing Partner Cory Mertz commented.
Read the full article: Q3 2022 Home Health, Hospice and Home Care M&A Update //
Source: https://www.mertztaggart.com/post/q3-2022-home-health-hospice-and-home-care-m-a-update